JPEL Private Equity Limited Sale of Celerion (3761X)

TIDMJPEL

RNS Number : 3761X

JPEL Private Equity Limited

24 November 2017

JPEL Private Equity Limited

Ground Floor

Cambridge House

Le Truchot, St Peter Port

Guernsey, GY1 1WD

www.jpelonline.com

SALE OF CELERION

   --      CELERION WAS JPEL'S 2(nd) LARGEST INVESTMENT AT 30 SEPTEMBER 2017 
   --      JPEL RECEIVED PROCEEDS OF APPROXIMATELY USD 44.5 MILLION 
   *              *              * 

GUERNSEY, 24 NOVEMBER 2017

MTS Health Investors, LLC ("MTS"), a healthcare-focused private equity firm, announced that its portfolio company Celerion Holdings, Inc. ("Celerion") has partnered with Court Square Capital Partners ("Court Square"). Court Square is investing in partnership with the Celerion management team, who will continue to own a minority interest in the Company. JPEL held an indirect interest in Celerion.

As part of the transaction, JPEL received proceeds of approximately USD $44.5 million.

At 30 September 2017, Celerion represented 8.1% of JPEL's private equity investments and was JPEL's 2(nd) largest underlying investment.

   *             *                   * 

About JPEL Private Equity Limited

JPEL Private Equity Limited is a Guernsey registered and incorporated, London Stock Exchange-listed, closed-ended investment company (LSE: JPEL) designed primarily to invest in the global private equity market. The investment objective of the Company is to achieve both short and long-term capital appreciation by investing in a well-diversified portfolio of private equity fund interests and by capitalising on the inefficiencies of the secondary private equity market.

ENQUIRIES:

FCF JPEL Management LLC

[e-mail]

This information is provided by RNS

The company news service from the London Stock Exchange

END

DISZXLFLDFFLFBL

(END) Dow Jones Newswires

November 24, 2017 02:00 ET (07:00 GMT)